Wheeler Bio, a biomanufacturing company built to accelerate the translation of therapeutic innovation into clinical impact, announced today the closing of a $14M Seed financing round. The round was co-led by Echo Investment Capital and Alloy Therapeutics, with participation from Floating Point and Presbyterian Health Foundation.
OKC’s pro soccer club to undergo community driven brand review
Process will involve regular listening sessions and consideration of a women’s team in the future